Treatment of Whooping Cough (Pertussis)
Azithromycin is the first-line antibiotic for treating pertussis across all age groups, with a 5-day course being as effective as traditional 14-day erythromycin regimens while causing significantly fewer gastrointestinal side effects. 1
Antibiotic Selection and Dosing
First-Line Treatment: Azithromycin
Azithromycin is the preferred agent due to superior tolerability, shorter treatment duration, and equal efficacy compared to erythromycin. 1, 2
Age-Specific Dosing:
- Infants <1 month: 10 mg/kg/day for 5 days (preferred over erythromycin due to significantly lower risk of infantile hypertrophic pyloric stenosis) 1
- Infants 1-5 months: 10 mg/kg/day for 5 days 1
- Infants ≥6 months and children: 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg/day (max 250 mg) on days 2-5 1
- Adults: 500 mg on day 1, then 250 mg daily on days 2-5 1
Alternative First-Line: Clarithromycin
- Infants 1-5 months: 15 mg/kg/day divided into two doses for 7 days 1
- Children and adults: 7.5 mg/kg twice daily (adults: 500 mg twice daily) for 7 days 1
Second-Line: Erythromycin
Erythromycin should be avoided in infants <1 month due to association with infantile hypertrophic pyloric stenosis (IHPS). 1, 3 If erythromycin must be used:
- Children: 40-50 mg/kg/day in divided doses for 14 days 1, 3
- Adults: 500 mg every 6 hours or 250 mg every 12 hours for 14 days 3
Alternative for Macrolide Contraindications
- Trimethoprim-sulfamethoxazole (TMP-SMZ): For patients >2 months with macrolide allergies or contraindications 1
Timing of Treatment: Critical for Effectiveness
Start antibiotics immediately upon clinical suspicion without waiting for culture confirmation. 1
Treatment Effectiveness by Disease Stage:
- Catarrhal phase (first 2 weeks): Antibiotics rapidly clear B. pertussis from the nasopharynx, decrease coughing paroxysms, and reduce complications 1
- Paroxysmal phase (>3 weeks): Limited clinical benefit for symptom control, but treatment still indicated to prevent transmission 1
- Key point: Antibiotics eliminate the organism and render patients non-infectious but do not alter the clinical course once paroxysmal cough is established 4, 2
Isolation Requirements
Isolate patients at home and away from work/school for 5 days after starting antibiotics to prevent transmission. 1 Pertussis has a secondary attack rate exceeding 80% among susceptible persons. 1
Important Medication Considerations
Azithromycin-Specific Precautions:
- Do not administer with aluminum- or magnesium-containing antacids (reduces absorption) 1
- Use with caution in patients with impaired hepatic function 1
Erythromycin-Specific Warnings:
- Contraindicated in infants <1 month due to IHPS risk 1
- Inhibits cytochrome P450 enzymes; monitor for drug interactions with digoxin, triazolam, ergot alkaloids 1
- Significantly higher gastrointestinal side effects (41% vs 19% with azithromycin) 2
Post-Exposure Prophylaxis
The same antibiotic regimens and doses used for treatment are recommended for post-exposure prophylaxis. 1, 5
Who Should Receive Prophylaxis:
- All household contacts regardless of vaccination status 5, 6
- High-risk contacts: Infants <12 months (especially <4 months), pregnant women in third trimester 1, 5
- Healthcare workers with known exposure 1
Timing:
- Administer within 21 days of exposure for effectiveness 6
- Prophylaxis aims to eradicate B. pertussis from the nasopharynx of infected persons (symptomatic or asymptomatic) 6
Therapies That Do NOT Work
Do not use β-agonists, antihistamines, corticosteroids, or pertussis immunoglobulin—these have no proven benefit in controlling coughing paroxysms. 1
Common Pitfalls to Avoid
- Waiting for culture confirmation before starting treatment: This delays therapy during the critical catarrhal phase when antibiotics are most effective 1
- Using erythromycin in young infants: The IHPS risk makes azithromycin strongly preferred in infants <6 months 1
- Expecting symptom improvement with late treatment: Once paroxysmal cough is established, antibiotics prevent transmission but don't improve symptoms 1, 4
- Poor compliance with erythromycin: Only 55% of patients complete the 14-day course vs 90% completing 5-day azithromycin 2
- Forgetting prophylaxis for household contacts: Creates a protective "cocoon" around vulnerable infants 5